The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
17 reports and counting
Retro Biosciences raises $1B Seed
Retro Biosciences raises $1B in Seed. Biotech company focused on extending healthy human lifespan by 10 years...
Retro Biosciences raises $1B Growth at $2B valuation
Retro Biosciences raises $1B in Growth at $2B valuation. Extending healthy human lifespan...
Treeline Biosciences raises $200M Series A
Treeline Biosciences raises $200M in Series A. Developer of medicines for cancer and serious diseases, total funding $1.1B...
Predicta Biosciences raises $23.4M Series A
Predicta Biosciences raises $23.4M in Series A. Precision medicine platform for predictive biomarker discovery...
Seran Bioscience raises $215M Series C
Seran Bioscience raises $215M in Series C. Biotech developing precision therapeutics for complex diseases...
Arsenal Biosciences raises $325M Series C
Arsenal Biosciences raises $325M in Series C. Cell therapy company developing programmable T-cell therapies for solid tumors...
Enveda Biosciences raises $150M Series D at $1B valuation
Enveda Biosciences raises $150M in Series D at $1B valuation. Drug discovery company studying plant chemistry to discover new medicines...
Colossal Biosciences raises $200M Series C at $10.2B valuation
Colossal Biosciences raises $200M in Series C at $10.2B valuation. De-extinction and genetic engineering...
Colossal Biosciences raises $120M Growth at $10.2B valuation
Colossal Biosciences raises $120M in Growth at $10.2B valuation. De-extinction company using genetic engineering to revive extinct species like mammoths...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.